Clinical Trial Detail

NCT ID NCT01829503
Title Phase II Study of Decitabine and Cytarabine for Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Pittsburgh
Indications

acute myeloid leukemia

Therapies

Cytarabine + Decitabine

Age Groups: senior

No variant requirements are available.